Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐d‐glucitol

Hemoglobin A1c (HbA1c), glycated albumin (GA) and 1,5‐anhydro‐d‐glucitol (1,5‐AG) are used as indicators of glycemic control, whereas continuous glucose monitoring (CGM) is used to assess daily glucose profiles. The aim of this study was to investigate the relationships between CGM metrics, such as time in range (TIR), and glycemic control indicators.

• Publication year

  2020

• Venue

  Journal of Diabetes Investigation

• Publication date

  2020-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jdi.13437PMID 33058513PMCID 8169363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes.

  2020influential reference
• Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐d‐glucitol

  2020cited by this paper
• Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes

  2020cited by this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cited by this paper
• Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study

  2020influential reference
• Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes

  2020cited by this paper
• Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

  2019cited by this paper
• 6. Glycemic Targets: Standards of Medical Care in Diabetes—2020

  2019cited by this paper
• The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c

  2019influential reference
• The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes

  2019cited by this paper
• Japanese Clinical Practice Guideline for Diabetes 2016

  2018cited by this paper
• Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes

  2018cited by this paper
• Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes

  2018cited by this paper
• International Consensus on Use of Continuous Glucose Monitoring

  2017cited by this paper
• Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.

  2015cited by this paper
• Glycated albumin; clinical usefulness.

  2014cited by this paper
• 1,5-Anhydroglucitol in diabetes mellitus

  2013cited by this paper
• Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus

  2013cited by this paper
• Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects.

  2012cited by this paper
• The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)

  2012cited by this paper
• Evaluation of 1,5‐anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls

  2012cited by this paper
• Angiotensin Converting Enzyme Insertion/Deletion Polymorphism and its Association with Complications in Patients with type 2 Diabetes Mellitus

  2012cited by this paper
• Continuous glucose monitoring system: Is it really accurate, safe and clinically useful?

  2012cited by this paper
• Converse contributions of fasting and postprandial glucose to HbA1c and glycated albumin

  2011cited by this paper
• Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control

  2009cited by this paper
• Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.

  2008cited by this paper
• Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients

  2008cited by this paper
• Association of erythrocyte indices with glycated haemoglobin in pre‐menopausal women

  2007cited by this paper
• Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

  2007cited by this paper
• Relationship between glycated haemoglobin levels and mean glucose levels over time

  2007cited by this paper
• A Novel Approach to Continuous Glucose Analysis Utilizing Glycemic Variation

  2005cited by this paper
• SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED)

  2004cited by this paper
• Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus

  1999cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial

  1995cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients

  1988cited by this paper
• Fructosamine: structure, analysis, and clinical usefulness.

  1987cited by this paper
• Reduction and Recovery of Plasma 1,5-Anhydro-D-Glucitol Level in Diabetes Mellitus

  1987cited by this paper
• Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes

  1982cited by this paper

• The Relationship Between Glycated Albumin and Time in Tight Range in Type 2 Diabetes

  2025cites this paper
• Detecting Hyperglycemia Using Biomarkers Versus Continuous Glucose Monitoring.

  2025cites this paper
• Association of time in tight range and 1,5‐anhydroglucitol in type 2 diabetes

  2025influential citation
• Effect Of Diabetes Self-Management and Education (DSME) On Hba1c Levels Of Patients With Diabetes Mellitus

  2025cites this paper
• The progress of clinical research on the detection of 1,5-anhydroglucitol in diabetes and its complications

  2024influential citation
• Seasonal fluctuations of CGM metrics in individuals with type 1 diabetes using an intermittently scanned CGM device or sensor augmented pump

  2024cites this paper
• Design of Machine Learning Algorithms and Internal Validation of a Kidney Risk Prediction Model for Type 2 Diabetes Mellitus

  2024cites this paper
• Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus

  2024cites this paper
• Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine

  2023cites this paper
• Research progress in the application of time in range: more than a percentage.

  2023cites this paper
• Novel clinical associations between time in range and microangiopathies in people with type 2 diabetes mellitus on hemodialysis.

  2023cites this paper
• Relationship Between Time in Range and Dusk Phenomenon in Outpatients with Type 2 Diabetes Mellitus

  2023cites this paper
• Correlation Between Glycemic Variability and Diabetic Complications: A Narrative Review

  2023cites this paper
• Associations between glycemic variability, sleep quality, and daily steps in subjects without diabetes using wearable devices

  2023cites this paper
• Correlation between time on target and glycated hemoglobin in people with diabetes mellitus: systematic review

  2023cites this paper
• Correlação entre tempo no alvo e hemoglobina glicada de pessoas com diabetes mellitus: revisão sistemática

  2023cites this paper
• Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study

  2022cites this paper
• Albuminuria as a biomarker of severity in diabetic retinopathy and in the response to intravitreal treatment in diabetic macular edema

  2022cites this paper
• Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes

  2022cites this paper
• The role Time in range depending on the method of assessing glycemic control in diabetes: A review

  2022cites this paper
• Glycaemia dynamics concepts before and after insulin.

  2022cites this paper
• „Time in range“ (TIR) vs. Glykohämoglobin Typ A1c (HbA1c): was zählt für unsere Patienten?

  2022cites this paper
• A rGO-PAM-Fc/AuNPs nanosensing membrane in a light-addressable potentiometric biosensor for 1,5-anhydroglucitol determination

  2022cites this paper
• Significance of Glycemic Variability in Diabetes Mellitus

  2021cites this paper
• Time in range correlates glycated albumin measured immediately after 2 weeks of continuous glucose monitoring.

  2021cites this paper
• The Optimal "Time in Range" and "Time below Range" are Difficult to Coordinate in Patients with Type 1 Diabetes.

  2021influential citation
• Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐d‐glucitol

  2020cites this paper